MXCT - MaxCyte GAAP EPS of -$0.10 in-line revenue of $9.04M misses by $1.62M August, 09 2023 04:57 PM MaxCyte Inc. 2023-08-09 16:57:09 ET MaxCyte press release ( NASDAQ: MXCT ): Q2 GAAP EPS of -$0.10 in-line. Revenue of $9.04M (-5.9% Y/Y) misses by $1.62M . Shares -4.59% . For further details see: MaxCyte GAAP EPS of -$0.10 in-line, revenue of $9.04M misses by $1.62M